The Journal of Infectious Diseases · 2022 · 36 citations · 26 references
Veterinary MedicineInfectious DiseasesPharmacoeconomicsCost-effectiveness AnalysisImmunizationVaccinologyCoverage AssessmentImmunization CoverageVaccinationVaccine EffectivenessVaccine EfficacyVaccine-preventable DiseasesCost-effectivenessCost-effectiveness Of VaccinationInfectious Disease EconomicsOverall Vaccine EffectivenessPopulation Health EquityPopulation-based Vaccine EffectivenessVaccination Coverage AnalysisVaccination Economics
BACKGROUND: Despite the advent of safe and effective coronavirus disease 2019 vaccines, pervasive inequities in global vaccination persist. METHODS: We projected health benefits and donor costs of delivering vaccines for up to 60% of the population in 91 low- and middle-income countries (LMICs). We modeled a highly contagious (Re at model start, 1.7), low-virulence (infection fatality ratio [IFR], 0.32%) "Omicron-like" variant and a similarly contagious "severe" variant (IFR, 0.59%) over 360 days, accounting for country-specific age structure and healthcare capacity. Costs included vaccination startup (US$630 million) and per-person procurement and delivery (US$12.46/person vaccinated). RESULTS: In the Omicron-like scenario, increasing current vaccination coverage to achieve at least 15% in each of the 91 LMICs would prevent 11 million new infections and 120 000 deaths, at a cost of US$0.95 billion, for an incremental cost-effectiveness ratio (ICER) of US$670/year of life saved (YLS). Increases in vaccination coverage to 60% would additionally prevent up to 68 million infections and 160 000 deaths, with ICERs <US$8000/YLS. ICERs were <US$4000/YLS under the more severe variant scenario and generally robust to assumptions about vaccine effectiveness, uptake, and costs. CONCLUSIONS: Funding expanded COVID-19 vaccine delivery in LMICs would save hundreds of thousands of lives, be similarly or more cost-effective than other donor-funded global aid programs, and improve health equity.
26
Temporal dynamics in viral shedding and transmissibility of COVID-19
Xi He, Eric H. Y. Lau, Peng Wu et al. · Nature Medicine · 2020 · 4.7K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
A global survey of potential acceptance of a COVID-19 vaccine
Jeffrey V. Lazarus, Scott C. Ratzan, Adam Palayew et al. · Nature Medicine · 2020 · 3.1K citations · Full text